NCI-CONNECTions: A Rare Brain and Spine Tumor Blog
Read news and information on advances in rare brain and spine tumor research, treatment, and education from our experts. To receive new posts via email, subscribe to our NCI-CONNECTions newsletter.
-
Dr. Terri Armstrong joined fellow leaders in the field of cancer survivorship to discuss the needs of those living with brain and spine tumors, as well as goals for the future and research funding opportunities.
-
Branch members shared poems, paintings, sculptures, and other works of art to display their creativity and build connections within the brain tumor community.
-
Research Nurse Tricia Kunst joined the Neuro-Oncology Branch in February 2022 after 21 years in the Thoracic Surgery Branch. She shares what she loves most about her job and the people she gets to meet along the way.
-
Glioblastoma survivor Dalouny continues to defy the odds and live life to the fullest with her family, friends, and a fulfilling career.
-
Jen has lived with an ependymoma for over eight years and undergone multiple treatments, including three brain surgeries. She shares how her determination to go back to work and find a good medical team has helped her live her best life.
-
Dr. Byram Ozer joins NCI-CONNECT to help care for and educate patients, while bringing together medical professionals to learn new skills and treatment approaches.
-
In the six years since it began, the Natural History Study has amassed an enormous database of information that is helping to improve treatment and quality of life for patients with rare central nervous system cancers.
-
NCI Neuro-Oncology Branch Chief Mark Gilbert received the American Brain Tumor Association’s Joel A. Gingras Jr. Award for spearheading brain tumor research collaborations and expanding clinical trial access.
-
NIH Clinical Center Social Worker Sylvia Stearn provides supportive counseling and resources to help patients with brain and spine tumors cope and transition to their new normal.
-
Molecular biologist Dr. Zied Abdullaev explains the value of methylation marks for improved accuracy and precision in diagnosing rare brain and spine tumors.